NovAccess Global Inc.
XSNXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001039466
NovAccess Global Inc. was delisted in 2026; its insiders filed their last Form 4 on Jun 4, 2024; no institution reported holding it in 13F filings for Q2 2026; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by NovAccess Global Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for NovAccess Global Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Cassarini John | Director | – | Jun 4, 2024 | 0 |
| Laird Neil J | Chief Financial Officer | 260,000 | Mar 15, 2023 | 0 |
| Anderson Jason Michael | Director | – | Mar 15, 2023 | 0 |
| Martin Daniel G. | 10% Owner | 1,502,670Indirect | Mar 14, 2022 | 0 |
| Morris-Irvin Dwain | Chief Executive Officer | 600Indirect | Mar 14, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2022 (view filing)12:30 PM ET | Jan 20 | 1 day | Laird Neil JChief Financial Officer | PPurchaseCommon Stock, no par value | +250.0K | $0.20 | +$50.0K | +2,500.0%260.0K after |